The groundbreaking approach of this peptide represents a major advance in the care of type 2 diabetes. Different to existing drugs, tirzepatide targets multiple pathways – the GLP-1 hormone and the GIP hormone – https://tirzepatidepeptide922119.slypage.com/42578139/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment